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CASE REPORT
Diagnostic cues for natural killer cell lymphoma: primary
nodal presentation and the role of in situ hybridisation for
Epstein-Barr virus encoded early small RNA in detecting
occult bone marrow involvement
C-S Chim, E S K Ma, F Loong, Y-L Kwong
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Natural killer (NK) cell lymphomas are rare, and atypical
features might lead to diagnostic pitfalls. This report
describes an unusual patient in whom lymphoma occurred
initially as isolated lymph node involvement, an exceptional
presentation of an almost exclusively extranodal disease.
Furthermore, during the terminal haemophagocytosis in the
bone marrow, lymphoma cells lost the expression of the NK
cell marker, CD56, making the histopathological diagnosis of
bone marrow involvement difficult. This was resolved by in
situ hybridisation for Epstein-Barr virus encoded small RNA,
which detected occult bone marrow infiltration.
L
ymphomas derived from natural killer (NK) cells have
been classified as a distinct entity in the recently proposed
World Health Organisation classification of haematolym-
phoid malignancies.1–4 NK cell lymphomas exhibit a broad
morphological spectrum, with angiocentricity and zonal
tumour necrosis frequent but not invariable histological
features. Furthermore, there is an almost invariable presence
of Epstein Barr virus (EBV) infection in the tumour cells,
which can be detected by in situ hybridisation (ISH) for EBV
encoded early small RNAs (EBERs).1–4 EBV clonality can be
shown by molecular analysis of the EBV terminal repeats.2 3
Immunophenotypically, the lymphoma cells classically
express CD2, cytoplasmic CD3e (but not surface CD3), and
CD56. Therefore, NK cell lymphomas show a characteristic
profile of CD2+, CD3e+, CD56+, EBER+.5
‘‘Because of their rarity, natural killer cell lymphomas are
challenges even to the experienced pathologist’’
Clinically, NK cell lymphomas often involve the nasal or
paranasal areas, and are referred to as nasal NK cell
lymphomas.4 6 They can also occur at extranasal sites,
including the skin, testis, gastrointestinal tract, and parotid
glands, and are referred to as nasal-type NK cell lympho-
mas.7–9 Rarely, the lymphoma can be disseminated with
multiorgan involvement at diagnosis, and is referred to as NK
cell lymphoma/leukaemia.8 10 Because primary nodal presen-
tation is highly unusual, the lymphoma is aptly referred to as
extranodal NK/T cell lymphoma, nasal type, in the World
Health Organisation classification.1
Because of their rarity, NK cell lymphomas are challenges
even to the experienced pathologist. Therefore, exceptional
features need to be reported and discussed because they may
constitute diagnostic pitfalls to the unwary.
CASE REPORT
A 59 year old man presented with intermittent fever, night
sweating, and left submandibular swelling. The submandib-
ular lymph node biopsy showed partial replacement by a
polymorphic infiltration of small to medium sized abnormal
lymphoid cells with a prominent eosinophilic infiltrate. Focal
angioinvasion by the abnormal lymphoid infiltrate was
identified (fig 1A, B). The abnormal lymphoid cells were
CD2+, surface CD32, CD3e+, and CD56+ (fig 1C). EBER was
strongly positive on ISH (fig 1D). Polymerase chain reaction
for the T cell receptor gene showed a germline configuration.
These findings confirmed the diagnosis of NK cell lymphoma.
To search for occult nasopharyngeal involvement, endoscopy
of the nasopharynx with random biopsies was performed, but
lymphoma was not seen. The serum lactate dehydrogenase
concentration was increased to 640 U/litre (normal, , 400).
Real time quantitative polymerase chain reaction11 showed
circulating plasma EBV DNA to be 1.46 103 copies/ml at
diagnosis. Further investigations showed no involvement of
other anatomical sites. The diagnosis was therefore primary
nodal NK cell lymphoma, Ann Arbor stage 1B. The patient
achieved complete remission with three courses of combina-
tion chemotherapy, which was consolidated with local
radiotherapy. He remained well until two years later when
he developed a refractory left leg ulcer associated with
enlarged left inguinal lymph nodes. Biopsy of the leg ulcer
confirmed recurrent NK cell lymphoma. There was no
apparent involvement of other sites. He received cisplatinum,
high dose cytosine arabinoside, and dexamethasone, together
with local irradiation to the leg ulcer. The response was poor,
and despite chemotherapy, he developed persistent fever,
hepatosplenomegaly, nodular lesions over the trunk and
limbs, and pancytopenia (haemoglobin, 84 g/litre; platelets,
466 109/litre; and white blood cell count, 1.26 109/litre).
Lactate dehydrogenase was extremely high at 5640 U/litre.
Bone marrow aspiration showed scattered atypical lymphoid
cells with prominent haemophagocytosis. Immunohistoche-
mical analysis did not reveal CD56+ cells (fig 2A–C), although
ISH showed multiple EBER positive lymphoid cells (fig 2D).
Computerised tomography of the thorax and abdomen
showed mediastinal lymphadenopathy and hepatosplenome-
galy. He deteriorated rapidly and died. A postmortem
examination was not permitted by the family.
DISCUSSION
This case showed some extraordinary features. First, the
lymphoma initially presented as the isolated involvement of a
lymph node, which is exceptional. In a review of 45 cases of
Abbreviations: EBER, Epstein-Barr virus encoded early small RNA;
EBV, Epstein-Barr virus; ISH, in situ hybridisation; NK, natural killer
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nasal-type (extranasal) CD56 positive lymphomas, only one
had primary nodal presentation, but this patient had
concurrent bone marrow involvement.8 In another series of
13 aggressive nodal T and NK/T cell lymphomas, only one had
a classic NK cell lymphoma profile (CD2+, CD32, CD56+,
EBER+).12 The low copy number of plasma EBV DNA at
presentation (1.46 103 copies/ml, compared with 105 to
1010 copies/ml for nasal and non-nasal NK cell lymphomas11)
Figure 1 Histopathology of a case of nodal natural killer cell lymphoma. (A) Lymph node biopsy, showing interfollicular areas expanded by abnormal
lymphoid cells with angioinvasion (haematoxylin eosin (H&E) stain; original magnification,640). (B) The neoplastic lymphoid cells were small to
medium in size, with prominent eosinophilic infiltration (H&E stain; original magnification,6200). (C) Immunostaining for CD56, showing abundant
positive lymphoma cells (original magnification,6200). (D) In situ hybridisation for Epstein-Barr virus encoded early small RNA, showing numerous
positive cells (original magnification,6200).
Figure 2 Histopathological features of bone marrow infiltration in relapsed natural killer cell lymphoma. (A) Trephine biopsy showing an interstitial
infiltrate of abnormal lymphoid cells. They were large in size, having coarse chromatin texture, 1–3 small nucleoli, and an appreciable amount of
cytoplasm (haematoxylin eosin stain; original magnification,61000). (B) Immunostaining for CD3, showing positive cells (original magnification,
61000). (C) Immunostaining for CD56, showing no positive cells (original magnification,61000). (D) In situ hybridisation for Epstein-Barr virus
encoded early small RNA, showing clusters of positive lymphoma cells.
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also supported isolated lymph node involvement. However,
other than the rare nodal presentation, this case showed
pathological and molecular features that were typical of NK
cell lymphoma. Furthermore, the terminal dissemination to
the skin, liver, spleen, and bone marrow is also common in
extranodal nasal or nasal-type NK cell lymphomas.4 8
‘‘CD56 should not be relied upon alone as a marker of
neoplastic natural killer cells’’
During the terminal phase of illness, our patient showed
peripheral blood pancytopenia with prominent bone marrow
haemophagocytosis. From a diagnostic viewpoint, the dis-
tinction between haemophagocytosis and lymphomatous
infiltration as a cause of the pancytopenia might not be
easy. Haemophagocytosis occurs commonly in the liver,
spleen, and bone marrow in NK cell lymphomas. It may be
reactive, and is itself not necessarily an indicator of
infiltration in the involved tissue.7 8 10 Furthermore, NK cell
lymphoma infiltration might be patchy and inconspicuous.
Immunohistochemical staining for CD56 offers a diagnostic
aid to identifying the lymphomatous cells.1 However, a
notable caveat is that the expression of CD56 on the
lymphoma cells might occasionally be lost at relapse.13 This
phenomenon was again seen in our patient, highlighting the
important point that CD56 should not be relied upon alone as
a marker of neoplastic NK cells.
This problem was overcome by the use of EBER-ISH. In
fact, EBER-ISH has been shown to be more sensitive than
CD56 immunostaining in detecting occult bone marrow
infiltration by NK cell lymphoma.14 Other ancillary markers
such as cytotoxic granule associated proteins (granzyme B,
TIA-1, and perforin), expressed in NK cell lymphoma but
rarely in other lymphomas, might also be helpful,1 although
their use has not been formally compared with EBER-ISH.
In conclusion, our case showed that NK cell lymphoma can
present atypically in the lymph node, and that both
immunohistochemical staining and EBER-ISH are necessary
in the histopathological diagnosis.
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Take home messages
N We describe an unusual patient in whom natural killer
(NK) cell lymphoma occurred initially as isolated lymph
node involvement, an exceptional presentation of an
almost exclusively extranodal disease
N During the terminal haemophagocytosis in the bone
marrow, lymphoma cells lost the expression of the NK
cell marker, CD56, making the histopathological
diagnosis of bone marrow involvement difficult
N This was resolved by in situ hybridisation for Epstein-
Barr virus encoded small RNA, which detected occult
bone marrow infiltration
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